Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer.

Autor: Anampa J; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA janampa@montefiore.org., Haque T; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Murakhovskaya I; Department of Oncology, Division of Hematology, Montefiore Medical Center, NY, USA., Wang Y; Department of Pathology, Montefiore Medical Center, NY, USA., Bachiashvili K; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Papazoglu C; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Pradhan K; Department of Developmental & Molecular Biology, NY, USA., Steidl UG; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA., Sparano JA; Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA., Verma A; Department of Oncology, Division of Hematology, Montefiore Medical Center, NY, USA.; Department of Developmental & Molecular Biology, NY, USA.
Jazyk: angličtina
Zdroj: Haematologica [Haematologica] 2018 Mar; Vol. 103 (3), pp. e98-e102. Date of Electronic Publication: 2017 Nov 30.
DOI: 10.3324/haematol.2017.181941
Databáze: MEDLINE